1. Home
  2. LQDA vs APPF Comparison

LQDA vs APPF Comparison

Compare LQDA & APPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$78.03

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo AppFolio Inc.

APPF

AppFolio Inc.

HOLD

Current Price

$154.33

Market Cap

5.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
APPF
Founded
2004
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.6B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
LQDA
APPF
Price
$78.03
$154.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
9
Target Price
$41.00
$286.78
AVG Volume (30 Days)
2.4M
347.3K
Earning Date
05-08-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
51.81
N/A
EPS
0.52
1.18
Revenue
$158,320,000.00
$950,822,000.00
Revenue This Year
$278.87
$19.69
Revenue Next Year
$57.13
$16.70
P/E Ratio
$147.92
$122.54
Revenue Growth
1031.18
19.72
52 Week Low
$11.85
$142.56
52 Week High
$78.25
$325.90

Technical Indicators

Market Signals
Indicator
LQDA
APPF
Relative Strength Index (RSI) 75.44 47.63
Support Level $31.23 $145.78
Resistance Level N/A $168.43
Average True Range (ATR) 4.14 7.77
MACD 0.40 -1.21
Stochastic Oscillator 91.55 38.11

Price Performance

Historical Comparison
LQDA
APPF

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About APPF AppFolio Inc.

AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.

Share on Social Networks: